查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439532

尿路阻塞治疗装置 - 全球市场回顾、竞争格局、市场预测（2030）

Urinary Tract Obstruction Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

在 2024 年至 2030 年的预测期内，泌尿道阻塞治疗设备的全球市场规模预计将以 4.2% 的复合年增长率成长。 由于膀胱癌、良性前列腺增生、尿路结石和肾结石等泌尿系统疾病病例的增加，该市场呈现出正面的成长趋势。 此外，肥胖等久坐生活方式、产品设计创新、全球老年人口增加以及外科手术数量增加等风险因素将在 2024-2030 年预测期内促进市场成长。

尿路阻塞治疗器械市场动态

在尿路阻塞治疗器材市场，由于多种因素的影响，产品需求不断增加。 主要因素包括全世界膀胱癌、良性前列腺增生、尿路结石、肾结石等泌尿系统疾病病例不断增加。

尿路阻塞最常见的原因是结石、血栓、肿瘤和乳头撕脱。 这些阻塞迅速发展并引起严重的肾绞痛，并伴随腰部疼痛、血尿、噁心、呕吐和发烧。

根据泌尿科基金会 (2022) 的数据，良性前列腺增生 (BPH) 的盛行率估计将从 50 岁至 60 岁男性的 50% 增加到 80 岁及以上男性的 90%。 有些男性突然停止排尿（称为急性尿路阻塞）。

根据欧洲泌尿外科协会（2019）的数据，尿路结石的盛行率从 1% 到 20% 不等，在加拿大、瑞典、美国等生活水准较高的国家，盛行率肾结石的发生率相当高（超过10%）。

根据美国国家肾臟基金会 (2022) 的数据，每年有超过 50 万人因肾结石问题前往急诊室就诊。

此外，久坐的生活方式增加，包括过量饮酒和减少液体摄取量，也可能导致肾结石的形成。 此外，由于不良饮食习惯和缺乏运动等久坐生活方式，肥胖是形成肾结石的危险因素，而肥胖负担的增加也将促进泌尿道阻塞治疗设备市场的成长。

根据世界卫生组织（WHO）（2022）的数据，2016年全球肥胖人数约6.5亿。 各种研究也表明，肥胖者会产生更多的尿酸和草酸钙结石，进一步阻碍尿液从体内正常排出。

此外，老年人更容易罹患末期肾病。 根据《世界人口展望》（2019），2019年全球65岁以上人口为7.03亿人。 因此，随着老年人口的增加，尿路结石的盛行率将会增加，从而增加对尿路阻塞治疗设备的需求，并推动全球尿路阻塞治疗设备市场的成长。

然而，设备成本高和不良事件等某些因素可能会对尿路阻塞治疗设备市场的成长产生一定的限制。

由于 COVID-19 大流行的爆发，急诊就诊人数大幅减少。 此外，门诊预约也被推迟，增加了虚拟和电话咨询的需求。 由于医院床位、麻醉和手术名额以及医务人员的短缺，这些变化造成了大量的治疗积压，并对全球尿路阻塞治疗设备市场产生了负面影响。

尿路阻塞治疗器械市场区隔分析

在尿路阻塞治疗设备市场的治疗领域，预计在预测期内（2024-2030年）体外震波碎石机将在尿路阻塞治疗设备市场中占据较高份额。 这可能是由于与这些设备相关的某些功能所造成的。

该产品领域的高市占率可归因于越来越多的患者采用这些设备和快速治疗。 ESWL 的主要优点是治疗完全非侵入性，因为结石治疗不涉及皮肤切口或使用侵入性手术器械。 相反，它使用衝击波将结石破碎成小块，并通过输尿管将其从膀胱排出。

本报告提供了全球尿路阻塞治疗设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章尿路阻塞治疗器材市场报告介绍

第2章尿路阻塞治疗设备市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估
  • 财务基准

第3章监理与专利分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章尿路阻塞治疗器材市场主要因素分析

  • 推动尿路阻塞治疗器械市场的因素
    • 泌尿系统疾病病例增加
    • 久坐的生活方式是危险因子
    • 产品设计创新
    • 世界各地老年人口成长
  • 尿路阻塞治疗器械市场的限制与挑战
    • 设备成本高
    • 不良事件
  • 尿路阻塞治疗装置市场机遇
    • 需要先进设备，消除诊疗不准确的困难
    • 新兴国家对微创设备的偏好日益增加

第5章泌尿道阻塞治疗器材市场波特五力分析

第6章COVID-19对泌尿道阻塞治疗器材市场的影响分析

第7章尿路阻塞治疗器材市场布局

  • 按产品
    • 导尿管
    • 尿路支架
    • 震波碎石机
    • 输尿管镜检查
    • 删除范围
    • 石材撷取设备
    • 雷射治疗系统
    • 其他
  • 依指示
    • 癌症
    • 微积分
    • 良性摄护腺增生 (BPH)
    • 肾积水
  • 按最终用户
    • 医院
    • 门诊手术中心
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第8章尿路阻塞治疗器材市场：全球公司份额分析 - 3至5家主要公司

第9章尿路阻塞治疗器材市场公司及产品概况

  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Advin Health Care
  • Inceler Medikal Co. Ltd.
  • Walz Elektronik GmbH
  • Cook
  • Becton, Dickinson, and Company
  • Teleflex Incorporated
  • STORZ MEDICAL AG
  • Olympus
  • EMS Urology
  • Dornier Medtech
  • Shockwave Medical Inc.
  • ACE Medical Devices Pvt. Ltd.
  • Applied Medical Resources Corporation
  • Richard Wolf GmbH
  • Stryker
  • Urocare Products, Inc.
  • J and M Urinary Catheters LLC
  • Rocamed

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

Product Code: DIMDCL0354

Urinary Tract Obstruction Treatment Devices Market By Product (Urinary Catheters [Indwelling/Foley Catheters, Intermittent Catheters, External Catheters], Urinary Stents, Shock Wave Lithotripters [Intracorporeal, Extracorporeal], Ureteroscopes [Semi-Rigid, Flexible], Resectoscopes, Stone Retrieval Devices, Laser Therapy Systems, Others), By Indication (Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to growing cases of urological disorders and innovation in product design

Global Urinary Tract Obstruction Treatment Devices Market growing at a CAGR of 4.2% during the forecast period from 2024 to 2030. The Urinary Tract Obstruction Treatment Devices market is witnessing positive growth owing to the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others. In addition, sedentary lifestyle such as obesity which is a risk factor, innovation in product design, rising old age population across the globe, increase in the number of surgical procedures is thereby contributing to the growth of the Urinary Tract Obstruction Treatment Devices market during the forecast period from 2024-2030.

Urinary Tract Obstruction Treatment Devices Market Dynamics:

The Urinary Tract Obstruction Treatment Devices market is witnessing a growth in product demand owing to various reasons. The key factor includes the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others across the globe.

The most common causes of urinary obstruction are calculi, blood clots, tumors, or sloughed papilla. These obstructions present acutely, leading to severe renal colic with flank pain, hematuria, nausea, vomiting, and fever.

As per The Urology Foundation 2022, the incidence of benign prostatic hyperplasia (BPH), was estimated to increase from 50% among men between the ages of 50 and 60 years to 90% for men older than 80 years of age. Some men experience a sudden onset of the inability to pass urine (known as acute retention).

According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).

According to the National Kidney Foundation 2022, over half a million people go to emergency rooms for kidney stone problems every year.

Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, and less consumption of water can also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a higher risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities will also contribute to the Urinary Tract Obstruction Treatment Devices market growth.

As per the World Health Organization (WHO) 2022 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies, obese people develop more uric acid stones and calcium oxalate stones, which further hinder the normal passing of urine from the body.

Also, the aging population is more prone to the risk of end-stage renal failure. As per the World Population Prospects, 2019, there were 703 million older persons aged 65 or over in 2019 globally. Therefore, as the aging population increases, there will be more prevalence of urolithiasis, which will eventually boost the demand for Urinary Tract Obstruction Treatment Devices which will drive the growth of the Global Urinary Tract Obstruction Treatment Devices market.

However, certain factors such as the high cost of devices and the adverse events may be certain limiting factors to the Urinary Tract Obstruction Treatment Devices market growth.

The outbreak of the COVID-19 pandemic caused a significant decrease in emergency department visits. Moreover, there was a delay in outpatient clinic appointments which pushed the need for virtual or telephone clinics. Due to a lack of in-hospital beds, anesthesia or procedural slots, and healthcare professionals, these changes created a significant backlog in the treatment, thereby creating a negative impact on the Global Urinary Tract Obstruction Treatment Devices market.

Urinary Tract Obstruction Treatment Devices Market Segment Analysis:

Urinary Tract Obstruction Treatment Devices Market By Product (Urinary Catheters [Indwelling/Foley Catheters, Intermittent Catheters, External Catheters], Urinary Stents, Shock Wave Lithotripters [Intracorporeal, Extracorporeal], Ureteroscopes [Semi-Rigid, Flexible], Resectoscopes, Stone Retrieval Devices, Laser Therapy Systems, Others), By Indication (Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Treatment segment of the Urinary Tract Obstruction Treatment Devices market, the Extracorporeal Shock Wave Lithotripters are estimated to hold a higher share in the Urinary Tract Obstruction Treatment Devices market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices.

The large market share of this product segment can be attributed to the growing patient adoption of these devices and quick treatment. The main benefit of ESWL is that the treatment is totally non-invasive, as it does not involve any skin incisions or the use of any invasive surgical instruments to treat the stone. Instead, shock waves are utilized to shatter the stone into tiny fragments that flow through the ureter and out of the bladder.

It also has other advantages such as reduced pain, quick recovery time, and shorter hospital stays. This treatment method is chosen by a majority of the patient and physician population.

ESWL is suited for small stones as well as certain stones are present in the upper portion of the ureter. Moreover, multiple stones can also be treated with ESWL. Therefore, it is expected that with such advantages offered by the Extracorporeal Shock Wave Lithotripsy Devices this technology is expected to increase its penetration in the coming years, thus this will drive the segment to grow during the forecast period, which will have a positive impact on the overall Global Urinary Tract Obstruction Treatment Devices Market growth.

Furthermore, Extracorporeal Shock Wave Lithotripsy Devices are gaining commercial acceptability, which also improves market penetration. All these advantages of these devices make physicians more inclined to use Extracorporeal Shock Wave Lithotripsy Devices.

Hence, all the above-mentioned factors are expected to drive the segment growth of the Urinary Tract Obstruction Treatment Devices market.

North America is expected to dominate the overall Urinary Tract Obstruction Treatment Devices Market:

Among all the regions, North America is expected to account for the largest share in the Global Urinary Tract Obstruction Treatment Devices market during the year 2022. Factors such as the growing cases of urological disorders such as bladder and prostate cancers, urolithiasis, or nephrolithiasis, among others, and increased risk of end-stage renal failure among the population, rising product approvals are expected to aid in the growth of the North America Urinary Tract Obstruction Treatment Devices Market.

In the United States, high prostate cancer cases in the region increase the demand for urinary catheters as it causes difficulties in urination. For instance, as per the American Cancer Society 2022 statistics, about 248,530 new cases of prostate cancer are reported in the same year.

The rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for an increase in the usage of Urinary Tract Obstruction Treatment Devices. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US.

Moreover, according to the Canadian cancer society 2020 data, around 12,200 Canadians were suffering from bladder cancer in the year 2020.

As per the Canadian Urological Association guidelines 2022, globally, the prevalence of urolithiasis is steadily increasing, and though some regional variability exists, contemporary estimates report up to 10%-12% of men and 7%-8% of women now suffer from nephrolithiasis.

Moreover, according to the US Department of Health and Human Services 2022, end-stage renal disease (ESRD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted.

Another factor responsible for the growth of the Urinary Tract Obstruction Treatment Devices market is the launch of new products in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US.

Thus, these factors are projected to contribute to the Urinary Tract Obstruction Treatment Devices market during the forecasted period.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Urinary Tract Obstruction Treatment Devices market during the forecast period.

Urinary Tract Obstruction Treatment Devices Market Key Players:

Some of the key market players operating in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed and others.

Recent Developmental Activities in the Urinary Tract Obstruction Treatment Devices Market:

In March 2022, Boston Scientific acquired Lumenis in a $1.07 billion deal. With this acquisition, Boston Scientific has strengthened its product portfolio for Lithotripsy devices. This will further add to the growth of the Global Urinary Tract Obstruction Treatment Devices market.

In March 2022, Dornier MedTech GmbH became the world's first integrated urology company to be certified by the European Union's Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products: Dornier Delta® III, one of the most powerful lithotripters that utilize Dornier's Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS(TM), a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.

In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.

In 2019, Shockwave Medical Inc. received breakthrough device designation for its intravascular lithotripsy (IVL) therapy, used for lithotripsy and was long used to eliminate kidney stones.

Key Takeaways from the Urinary Tract Obstruction Treatment Devices Market Report Study

  • Market size analysis for current Urinary Tract Obstruction Treatment Devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urinary Tract Obstruction Treatment Devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global Urinary Tract Obstruction Treatment Devices market.
  • Various opportunities available for the other competitor in the Urinary Tract Obstruction Treatment Devices market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030?
  • Which is the top-performing regions and countries in the current Urinary Tract Obstruction Treatment Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Urinary Tract Obstruction Treatment Devices market growth in the coming future?

Target Audience who can be benefited from this Urinary Tract Obstruction Treatment Devices Market Report Study

  • Urinary Tract Obstruction Treatment Devices products providers
  • Research organizations and consulting companies
  • Urinary Tract Obstruction Treatment Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Urinary Tract Obstruction Treatment Devices
  • Various End-users who want to know more about the Urinary Tract Obstruction Treatment Devices market and latest technological developments in the Urinary Tract Obstruction Treatment Devices market.

Frequently Asked Questions for the Urinary Tract Obstruction Treatment Devices Market:

1. What are Urinary Tract Obstruction Treatment Devices?

Urinary Tract Obstruction Treatment Devices are devices used to treat obstruction which occurs in the course of urine from the kidney to the urethra.

2. What is the market for Global Urinary Tract Obstruction Treatment Devices?

Global Urinary Tract Obstruction Treatment Devices Market growing at a CAGR of 4.2% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Urinary Tract Obstruction Treatment Devices Market?

The Urinary Tract Obstruction Treatment Devices market is witnessing a positive market growth owing to the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others. In addition, sedentary lifestyle such as obesity which is a risk factor, innovation in product design, rising old age population across the globe, increase in the number of surgical procedures is thereby contributing to the growth of the Urinary Tract Obstruction Treatment Devices market.

4. Who are the key players operating in the Global Urinary Tract Obstruction Treatment Devices Market?

Some of the key market players operating in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.

5. Which region has the highest share in Urinary Tract Obstruction Treatment Devices Market?

North America is expected to hold the highest share in the revenue in the Urinary Tract Obstruction Treatment Devices market during the forecast period. Factors such as the growing cases of urological disorders such as bladder and prostate cancers, urolithiasis, or nephrolithiasis, among others, and increased risk of end-stage renal failure among the population, rising product approvals, are expected to aid in the growth of North America Urinary Tract Obstruction Treatment Devices Market in this region.

Table of Contents

1.Urinary Tract Obstruction Treatment Devices Market Report Introduction

2.Urinary Tract Obstruction Treatment Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Urinary Tract Obstruction Treatment Devices Market Key Factors Analysis

  • 4.1. Urinary Tract Obstruction Treatment Devices Market Drivers
    • 4.1.1. The Growing Cases of Urological Disorders
    • 4.1.2. Sedentary Lifestyle as a Risk Factor
    • 4.1.3. Innovation in Product Design
    • 4.1.4. Rising Old Age Population Across the Globe
  • 4.2. Urinary Tract Obstruction Treatment Devices Market Restraints and Challenges
    • 4.2.1. The High Cost of Devices
    • 4.2.2. The Adverse Events
  • 4.3. Urinary Tract Obstruction Treatment Devices Market Opportunities
    • 4.3.1. Need For Advanced Devices to Eliminate Inaccurate Diagnosis and Difficulties in Treatment
    • 4.3.2. Growing Preference in Emerging Countries For Minimally Invasive Devices

5. Urinary Tract Obstruction Treatment Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Urinary Tract Obstruction Treatment Devices Market

7. Urinary Tract Obstruction Treatment Devices Market Layout

  • 7.1. By Product
    • 7.1.1. Urinary Catheters
      • 7.1.1.1. Indwelling/Foley Catheters
      • 7.1.1.2. Intermittent Catheters
      • 7.1.1.3. External Catheters
    • 7.1.2. Urinary Stents
    • 7.1.3. Shock Wave Lithotripters
      • 7.1.3.1. Intracorporeal
      • 7.1.3.2. Extracorporeal
    • 7.1.4. Ureteroscopes
      • 7.1.4.1. Semi-Rigid
      • 7.1.4.2. Flexible
    • 7.1.5. Resectoscopes
    • 7.1.6. Stone Retrieval Devices
    • 7.1.7. Laser Therapy Systems
    • 7.1.8. Others
  • 7.2. By Indication
    • 7.2.1. Cancers
    • 7.2.2. Stones
    • 7.2.3. Benign Prostatic Hyperplasia (BPH)
    • 7.2.4. Hydronephrosis
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.1.2. North America Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.1.3. North America Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.1.4. North America Urinary Tract Obstruction Treatment Devices Market, by Country
      • 7.4.1.4.1. United States
      • 7.4.1.4.2. Canada
      • 7.4.1.4.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.2.2. Europe Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.2.3. Europe Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.2.4. Europe Urinary Tract Obstruction Treatment Devices Market, by Country
      • 7.4.2.4.1. France
      • 7.4.2.4.2. Germany
      • 7.4.2.4.3. United Kingdom
      • 7.4.2.4.4. Italy
      • 7.4.2.4.5. Spain
      • 7.4.2.4.6. Russia
      • 7.4.2.4.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.3.2. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.3.3. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.4.2. RoW Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.4.3. RoW Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.4.4. RoW Urinary Tract Obstruction Treatment Devices Market, by Region
      • 7.4.4.4.1. Middle East
      • 7.4.4.4.2. Africa
      • 7.4.4.4.3. South America

8. Urinary Tract Obstruction Treatment Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Urinary Tract Obstruction Treatment Devices Market Company and Product Profiles

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. B. Braun Melsungen AG
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Advin Health Care
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Inceler Medikal Co. Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Walz Elektronik GmbH
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Cook
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Becton, Dickinson, and Company
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Teleflex Incorporated
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. STORZ MEDICAL AG
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Olympus
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. EMS Urology
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Dornier Medtech
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Shockwave Medical Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. ACE Medical Devices Pvt. Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Applied Medical Resources Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Richard Wolf GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Stryker
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Urocare Products, Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. J and M Urinary Catheters LLC
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Rocamed
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. PROJECT APPROACH

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Urinary Tract Obstruction Treatment Devices Market in Global (2021-2030)
  • Table 4: Urinary Tract Obstruction Treatment Devices Market in Global by Product (2021-2030)
  • Table 5: Urinary Tract Obstruction Treatment Devices Market in Global by Indication (2021-2030)
  • Table 6: Urinary Tract Obstruction Treatment Devices Market in Global by End User (2021-2030)
  • Table 7: Urinary Tract Obstruction Treatment Devices Market in Global by Geography (2021-2030)
  • Table 8: Urinary Tract Obstruction Treatment Devices Market in North America (2021-2030)
  • Table 9: Urinary Tract Obstruction Treatment Devices Market in North America by Product (2021-2030)
  • Table 10: Urinary Tract Obstruction Treatment Devices Market in North America by Indication (2021-2030)
  • Table 11: Urinary Tract Obstruction Treatment Devices Market in North America by End User (2021-2030)
  • Table 12: Urinary Tract Obstruction Treatment Devices Market in North America by Country (2021-2030)
  • Table 13: Urinary Tract Obstruction Treatment Devices Market in the US (2021-2030)
  • Table 14: Urinary Tract Obstruction Treatment Devices Market in Canada (2021-2030)
  • Table 15: Urinary Tract Obstruction Treatment Devices Market in Mexico (2021-2030)
  • Table 16: Urinary Tract Obstruction Treatment Devices Market in Europe (2021-2030)
  • Table 17: Urinary Tract Obstruction Treatment Devices Market in Europe by Product (2021-2030)
  • Table 18: Urinary Tract Obstruction Treatment Devices Market in Europe by Indication (2021-2030)
  • Table 19: Urinary Tract Obstruction Treatment Devices Market in Europe by End User (2021-2030)
  • Table 20: Urinary Tract Obstruction Treatment Devices Market in Europe by Country (2021-2030)
  • Table 21: Urinary Tract Obstruction Treatment Devices Market in France (2021-2030)
  • Table 22: Urinary Tract Obstruction Treatment Devices Market in Germany (2021-2030)
  • Table 23: Urinary Tract Obstruction Treatment Devices Market in the United Kingdom (2021-2030)
  • Table 24: Urinary Tract Obstruction Treatment Devices Market in Italy (2021-2030)
  • Table 25: Urinary Tract Obstruction Treatment Devices Market in Spain (2021-2030)
  • Table 26: Urinary Tract Obstruction Treatment Devices Market in Russia (2021-2030)
  • Table 27: Urinary Tract Obstruction Treatment Devices Market in Rest of Europe (2021-2030)
  • Table 28: Urinary Tract Obstruction Treatment Devices Market in APAC (2021-2030)
  • Table 29: Urinary Tract Obstruction Treatment Devices Market in APAC by Product (2021-2030)
  • Table 30: Urinary Tract Obstruction Treatment Devices Market in APAC by Indication (2021-2030)
  • Table 31: Urinary Tract Obstruction Treatment Devices Market in APAC by End User (2021-2030)
  • Table 32: Urinary Tract Obstruction Treatment Devices Market in APAC by Country (2021-2030)
  • Table 33: Urinary Tract Obstruction Treatment Devices Market in China (2021-2030)
  • Table 34: Urinary Tract Obstruction Treatment Devices Market in Japan (2021-2030)
  • Table 35: Urinary Tract Obstruction Treatment Devices Market in India (2021-2030)
  • Table 36: Urinary Tract Obstruction Treatment Devices Market in Australia (2021-2030)
  • Table 37: Urinary Tract Obstruction Treatment Devices Market in South Korea (2021-2030)
  • Table 38: Urinary Tract Obstruction Treatment Devices Market in Rest of APAC (2021-2030)
  • Table 39: Urinary Tract Obstruction Treatment Devices Market in Rest of World (2021-2030)
  • Table 40: Urinary Tract Obstruction Treatment Devices Market in RoW by Product (2021-2030)
  • Table 41: Urinary Tract Obstruction Treatment Devices Market in RoW by Indication (2021-2030)
  • Table 42: Urinary Tract Obstruction Treatment Devices Market in RoW by End User (2021-2030)
  • Table 43: Urinary Tract Obstruction Treatment Devices Market in RoW by Region (2021-2030)
  • Table 44: Urinary Tract Obstruction Treatment Devices Market in Middle East (2021-2030)
  • Table 45: Urinary Tract Obstruction Treatment Devices Market in Africa (2021-2030)
  • Table 46: Urinary Tract Obstruction Treatment Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Urinary Tract Obstruction Treatment Devices Market in Global (2021-2030)
  • Figure 4: Urinary Tract Obstruction Treatment Devices Market in Global by Product (2021-2030)
  • Figure 5: Urinary Tract Obstruction Treatment Devices Market in Global by Indication (2021-2030)
  • Figure 6: Urinary Tract Obstruction Treatment Devices Market in Global by End User (2021-2030)
  • Figure 7: Urinary Tract Obstruction Treatment Devices Market in Global by Geography (2021-2030)
  • Figure 8: Urinary Tract Obstruction Treatment Devices Market in North America (2021-2030)
  • Figure 9: Urinary Tract Obstruction Treatment Devices Market in North America by Product (2021-2030)
  • Figure 10: Urinary Tract Obstruction Treatment Devices Market in North America by Indication (2021-2030)
  • Figure 11: Urinary Tract Obstruction Treatment Devices Market in North America by End User (2021-2030)
  • Figure 12: Urinary Tract Obstruction Treatment Devices Market in North America by Country (2021-2030)
  • Figure 13: Urinary Tract Obstruction Treatment Devices Market in the US (2021-2030)
  • Figure 14: Urinary Tract Obstruction Treatment Devices Market in Canada (2021-2030)
  • Figure 15: Urinary Tract Obstruction Treatment Devices Market in Mexico (2021-2030)
  • Figure 16: Urinary Tract Obstruction Treatment Devices Market in Europe (2021-2030)
  • Figure 17: Urinary Tract Obstruction Treatment Devices Market in Europe by Product (2021-2030)
  • Figure 18: Urinary Tract Obstruction Treatment Devices Market in Europe by Indication (2021-2030)
  • Figure 19: Urinary Tract Obstruction Treatment Devices Market in Europe by End User (2021-2030)
  • Figure 20: Urinary Tract Obstruction Treatment Devices Market in Europe by Country (2021-2030)
  • Figure 21: Urinary Tract Obstruction Treatment Devices Market in France (2021-2030)
  • Figure 22: Urinary Tract Obstruction Treatment Devices Market in Germany (2021-2030)
  • Figure 23: Urinary Tract Obstruction Treatment Devices Market in the United Kingdom (2021-2030)
  • Figure 24: Urinary Tract Obstruction Treatment Devices Market in Italy (2021-2030)
  • Figure 25: Urinary Tract Obstruction Treatment Devices Market in Spain (2021-2030)
  • Figure 26: Urinary Tract Obstruction Treatment Devices Market in Russia (2021-2030)
  • Figure 27: Urinary Tract Obstruction Treatment Devices Market in Rest of Europe (2021-2030)
  • Figure 28: Urinary Tract Obstruction Treatment Devices Market in APAC (2021-2030)
  • Figure 29: Urinary Tract Obstruction Treatment Devices Market in APAC by Product (2021-2030)
  • Figure 30: Urinary Tract Obstruction Treatment Devices Market in APAC by Indication (2021-2030)
  • Figure 31: Urinary Tract Obstruction Treatment Devices Market in APAC by End User (2021-2030)
  • Figure 32: Urinary Tract Obstruction Treatment Devices Market in APAC by Country (2021-2030)
  • Figure 33: Urinary Tract Obstruction Treatment Devices Market in China (2021-2030)
  • Figure 34: Urinary Tract Obstruction Treatment Devices Market in Japan (2021-2030)
  • Figure 35: Urinary Tract Obstruction Treatment Devices Market in India (2021-2030)
  • Figure 36: Urinary Tract Obstruction Treatment Devices Market in Australia (2021-2030)
  • Figure 37: Urinary Tract Obstruction Treatment Devices Market in South Korea (2021-2030)
  • Figure 38: Urinary Tract Obstruction Treatment Devices Market in Rest of APAC (2021-2030)
  • Figure 39: Urinary Tract Obstruction Treatment Devices Market in Rest of World (2021-2030)
  • Figure 40: Urinary Tract Obstruction Treatment Devices Market in RoW by Product (2021-2030)
  • Figure 41: Urinary Tract Obstruction Treatment Devices Market in RoW by Indication (2021-2030)
  • Figure 42: Urinary Tract Obstruction Treatment Devices Market in RoW by End User (2021-2030)
  • Figure 43: Urinary Tract Obstruction Treatment Devices Market in RoW by Region (2021-2030)
  • Figure 44: Urinary Tract Obstruction Treatment Devices Market in Middle East (2021-2030)
  • Figure 45: Urinary Tract Obstruction Treatment Devices Market in Africa (2021-2030)
  • Figure 46: Urinary Tract Obstruction Treatment Devices Market in South America (2021-2030)
  • Figure 47: Market Drivers
  • Figure 48: Market Barriers
  • Figure 49: Marker Opportunities
  • Figure 50: PORTER'S Five Force Analysis